Welcome to our dedicated page for Cabot SEC filings (Ticker: CBT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating the carbon black margin tables or environmental reserve footnotes in Cabot Corporation’s 250-page annual report can feel like hunting for a pigment in a dark vat. Our SEC Filings hub fixes that problem in seconds.
Stock Titan’s AI deciphers complexity: every Cabot Corporation annual report 10-K is auto-summarized, giving you a plain-English view of feedstock cost sensitivity, regional capacity additions, and sustainability liabilities. Need the latest Cabot Corporation quarterly earnings report 10-Q filing? It lands here the moment EDGAR releases it, paired with trend charts and ratio analysis.
Stop refreshing for insider trades—this page streams Cabot Corporation Form 4 insider transactions real-time. Track executive stock transactions before pricing cycles shift, and review historical Cabot Corporation insider trading Form 4 transactions for pattern analysis.
Unsure which filing answers your question? Type it naturally—“understanding Cabot Corporation SEC documents with AI” or “Cabot Corporation 8-K material events explained”—and our engine points you to the exact section. You’ll also find:
- Cabot Corporation proxy statement executive compensation details with clear charts
- Cabot Corporation earnings report filing analysis highlighting segment EBIT swings
- Cabot Corporation annual report 10-K simplified into key risks and opportunities
Whether you’re a tire-sector analyst comparing reinforcement material margins or an ESG specialist reviewing remediation liabilities, our comprehensive coverage—with AI-powered summaries, real-time alerts, and clean navigation—lets you focus on decisions, not document mining.
Alpha Teknova, Inc. (TKNO) – Form 4 insider transaction
Director Martha J. Demski reported a single open-market sale of the company’s common stock on 27 June 2025. The transaction was executed under a Rule 10b5-1 trading plan adopted 12 March 2025 and was expressly intended to cover tax obligations arising from the vesting of director restricted stock units.
- Securities sold: 8,000 common shares
- Sale price: $5.064 per share
- Gross proceeds: approximately $40,512
- Post-transaction ownership: 12,000 common shares held directly
No derivative securities were acquired or disposed of, and no other transactions were reported. After the sale, Demski retains a direct equity interest in the company, but her share count declined by 40% from 20,000 to 12,000 shares. Because the disposition was pre-programmed under a 10b5-1 plan and earmarked for tax withholding, it is generally viewed as administrative rather than indicative of a changed outlook. Nevertheless, investors often monitor insider sales—especially by board members—for potential signaling effects. The filing does not disclose any changes to Demski’s role, company strategy, or financial performance.
Alpha Teknova, Inc. (TKNO) – Form 4 insider transaction
Director Martha J. Demski reported a single open-market sale of the company’s common stock on 27 June 2025. The transaction was executed under a Rule 10b5-1 trading plan adopted 12 March 2025 and was expressly intended to cover tax obligations arising from the vesting of director restricted stock units.
- Securities sold: 8,000 common shares
- Sale price: $5.064 per share
- Gross proceeds: approximately $40,512
- Post-transaction ownership: 12,000 common shares held directly
No derivative securities were acquired or disposed of, and no other transactions were reported. After the sale, Demski retains a direct equity interest in the company, but her share count declined by 40% from 20,000 to 12,000 shares. Because the disposition was pre-programmed under a 10b5-1 plan and earmarked for tax withholding, it is generally viewed as administrative rather than indicative of a changed outlook. Nevertheless, investors often monitor insider sales—especially by board members—for potential signaling effects. The filing does not disclose any changes to Demski’s role, company strategy, or financial performance.
Alpha Teknova, Inc. (TKNO) – Form 4 insider transaction
Director Martha J. Demski reported a single open-market sale of the company’s common stock on 27 June 2025. The transaction was executed under a Rule 10b5-1 trading plan adopted 12 March 2025 and was expressly intended to cover tax obligations arising from the vesting of director restricted stock units.
- Securities sold: 8,000 common shares
- Sale price: $5.064 per share
- Gross proceeds: approximately $40,512
- Post-transaction ownership: 12,000 common shares held directly
No derivative securities were acquired or disposed of, and no other transactions were reported. After the sale, Demski retains a direct equity interest in the company, but her share count declined by 40% from 20,000 to 12,000 shares. Because the disposition was pre-programmed under a 10b5-1 plan and earmarked for tax withholding, it is generally viewed as administrative rather than indicative of a changed outlook. Nevertheless, investors often monitor insider sales—especially by board members—for potential signaling effects. The filing does not disclose any changes to Demski’s role, company strategy, or financial performance.
FAQ
What is the current stock price of Cabot (CBT)?
What is the market cap of Cabot (CBT)?
What are the primary business segments of Cabot Corporation?
How does Cabot Corporation generate its revenue?
What industries are served by Cabot Corporation's products?
What distinguishes Cabot Corporation in the specialty chemicals market?
How does the company maintain its operational excellence?
Can you explain the significance of the reinforcement materials segment?
What role do performance chemicals play in Cabot's product portfolio?
How does Cabot Corporation address the challenges of its market?
